These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The financial implications of coverage of smoking cessation treatment by managed care organizations. Warner KE; Mendez D; Smith DG Inquiry; 2004; 41(1):57-69. PubMed ID: 15224960 [TBL] [Abstract][Full Text] [Related]
3. Should managed care organizations pay for nicotine replacement therapy? Westman EC Am J Manag Care; 1997 Feb; 3(2):335-7. PubMed ID: 10169267 [No Abstract] [Full Text] [Related]
4. By the numbers. Health plans and coverage of prescription drugs. Thornton D Healthplan; 1998; 39(6):77-8. PubMed ID: 10351351 [No Abstract] [Full Text] [Related]
17. Responding to consumer demand for choice, flexibility. Brainerd M Healthplan; 2002; 43(4):13-7. PubMed ID: 12221770 [No Abstract] [Full Text] [Related]
18. Purchasing health insurance coverage for smoking cessation treatment: employers describe the most influential information in this decision. Woolf NH; Burns ME; Bosworth TW; Fiore MC Nicotine Tob Res; 2006 Dec; 8(6):717-25. PubMed ID: 17132519 [TBL] [Abstract][Full Text] [Related]
19. A new method for determining patient payments for outpatient drugs. Goldman DP; Lakdawalla D Am J Manag Care; 2002 Feb; 8(2):125, 128, 130. PubMed ID: 11853200 [No Abstract] [Full Text] [Related]
20. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Fendrick AM; Smith DG; Chernew ME; Shah SN Am J Manag Care; 2001 Sep; 7(9):861-7. PubMed ID: 11570020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]